The Prognostic Impact of Duration of Anemia During Chemotherapy in Advanced Epithelial Ovarian Cancer
The Oncologist, 08/30/2011
Clinical Article
Kim JH et al. – Hb1020, based on the duration of anemia, is a potential prognostic factor for epithelial ovarian cancer. Using Hb1020, the authors will be able to administer highly optimized treatment for anemia to improve patient survival.







